Story thread · 2 reports / 2 sources

GSK expands myeloma pipeline in deal worth up to $750M

seekingalpha.com · 9h · first report

The coverage

STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more
statnews.com · 2h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.